Mark Perrin
2017
In 2017, Mark Perrin earned a total compensation of $2.5M as Former Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings, a 233% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,134,088 |
|---|---|
| Salary | $537,539 |
| Other | $799,705 |
| Total | $2,471,333 |
Perrin received $1.1M in option awards, accounting for 46% of the total pay in 2017.
Perrin also received $537.5K in salary and $799.7K in other compensation.
Rankings
In 2017, Mark Perrin's compensation ranked 4,482nd out of 14,666 executives tracked by ExecPay. In other words, Perrin earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,482 out of 14,666 | 69th |
Division Manufacturing | 1,579 out of 5,772 | 73rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 213 out of 859 | 75th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 113 out of 531 | 79th |
Industry Surgical and Medical Instruments and Apparatus | 69 out of 336 | 80th |
Source: SEC filing on April 27, 2018.
Perrin's colleagues
We found six more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2017.
2017
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
2017
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
2017
Tamara Joseph
InVivo Therapeutics Holdings
General Counsel
2017
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
2017
Pamela Stahl
InVivo Therapeutics Holdings
Former Chief Commercial Officer
2017
Melanie Morel-Ferris
InVivo Therapeutics Holdings